Dr. Lager is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Noaddress Ln
Hollis, NH 03049Phone+1 919-260-5625
Education & Training
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2002 - 2005
University of North Carolina HospitalsResidency, Pediatrics, 1999 - 2001
Duke University School of MedicineClass of 1998
Publications & Presentations
PubMed
- 102 citationsLocal delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models.Christian Hotz, Timothy R. Wagenaar, Friederike Gieseke, Dinesh S. Bangari, Michelle Callahan
Science Translational Medicine. 2021-09-08 - 12 citationsPhase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid TumorsGerald M. Edelman, Jordi Rodon, Joanne Lager, Christelle Castell, Jason Jiang
The Oncologist. 2018-04-01 - 41 citationsVoxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trialJennifer R. Brown, Mehdi Hamadani, John Hayslip, Ann Janssens, Nina D. Wagner-Johnston
The Lancet. Haematology. 2018-04-01
Press Mentions
NiKang Therapeutics Doses First Patient in a Phase 1/1b Study of NKT3447, an Oral, Selective Inhibitor of CDK2 Which Reduces Cyclin E ExpressionApril 15th, 2024
NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical OfficerJanuary 4th, 2024
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical OfficerMarch 26th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
